This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Japan Tobacco Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Tamotsu Negoro: Innovator in Cyclopropane Compounds
Introduction
Tamotsu Negoro is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cyclopropane compounds. His research focuses on developing therapeutic agents for conditions such as osteoarthritis and rheumatoid arthritis.
Latest Patents
Tamotsu Negoro holds a patent for "Cyclopropane compounds and pharmaceutical use thereof." This invention provides a compound with aggrecanase inhibitory activity and MMP-13 inhibitory activity. It is particularly useful as a therapeutic agent for osteoarthritis and rheumatoid arthritis. The patent details a cyclopropane compound of a specific formula, which includes various substituents and configurations that enhance its therapeutic potential.
Career Highlights
Negoro is currently associated with Japan Tobacco Inc., where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical compounds that address significant health issues.
Collaborations
He collaborates with esteemed colleagues such as Takashi Inaba and Julia Haas, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Tamotsu Negoro's contributions to the field of pharmaceuticals through his innovative cyclopropane compounds highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also has the potential to improve the quality of life for many individuals suffering from debilitating conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
